Detalhe da pesquisa
1.
CDK4/6 inhibition triggers anti-tumour immunity.
Nature
; 548(7668): 471-475, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813415
2.
Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancer.
Breast Cancer Res
; 24(1): 17, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248122
3.
Cationic Nanogel-mediated Runx2 and Osterix siRNA Delivery Decreases Mineralization in MC3T3 Cells.
Clin Orthop Relat Res
; 473(6): 2139-49, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25448327
4.
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors.
Cancer Discov
; 14(3): 446-467, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047585
5.
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.
Nat Cancer
; 2(1): 34-48, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33997789
6.
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
Cancer Cell
; 29(3): 255-269, 2016 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26977878
7.
Cationic nanostructured polymers for siRNA delivery in murine calvarial pre-osteoblasts.
J Biomed Nanotechnol
; 10(6): 1130-6, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24749407